Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

305
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
305
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

15
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
15
Autoimmune Disorders01:29

Autoimmune Disorders

529
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
529
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

612
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
612

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Single-cell RNA profiling of oligodendroglial lineage cells derived from iPSCs carrying Parkinson's disease-relevant LRRK2-G2019S mutation.

iScience·2026
Same author

New insights in multiple sclerosis pathology.

Current opinion in neurology·2026
Same author

Correction: Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis.

Journal of neuroinflammation·2026
Same author

In silico screening and preclinical validation identify bavisant as a therapeutic candidate for multiple sclerosis.

Science translational medicine·2026
Same author

Toward a Neuroimaging Consensus for the Work-up of Adult Genetic Leukoencephalopathies on Behalf of the White Matter Rounds Network: State of Practice.

AJNR. American journal of neuroradiology·2025
Same author

Development of a Human Preclinical Platform for the Identification of Neuroprotective Compounds.

The European journal of neuroscience·2025
Same journal

Alzheimer's disease in the <i>Plasticene</i> era: a clinicopathological update on the dual sequestration of amyloid and tau as hijacked innate immune responses.

Free neuropathology·2026
Same journal

An integrated multiscale imaging workflow to resolve intracellular co-pathology in human FFPE brain tissue.

Free neuropathology·2026
Same journal

Unclassifiable senile plaques and extensive cerebral amyloid angiopathy involving spinal and bridging vessels in autopsied patients with Down syndrome.

Free neuropathology·2026
Same journal

Brain extraction for fixed tissue banking: a technical report.

Free neuropathology·2026
Same journal

Forensic neuropathology: 2026 update.

Free neuropathology·2026
Same journal

Mass spectrometry imaging-based explainable machine learning reveals the biochemical landscapes of the mouse brain.

Free neuropathology·2026
查看所有相关文章

相关实验视频

Updated: Jul 27, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.1K

多发性硬化症:2023年更新

Tanja Kuhlmann1,2, Jack Antel2

  • 1Institute of Neuropathology, University Hospital Münster, 48149 Münster, Germany.

Free neuropathology
|June 7, 2023
PubMed
概括
此摘要是机器生成的。

2022年多发性硬化症 (MS) 研究的重点是了解疾病进展独立于复发,并探索新的疾病,如MOGAD. 新的见解旨在解决治疗渐进性多发性硬化和相关的中枢神经系统炎症疾病的挑战.

关键词:
这是EBV的EBV.多发性硬化症是多发性硬化症.雷米林的产生病变缓慢扩大,病变缓慢扩大.空间转录组学 空间转录组学

更多相关视频

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.5K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.5K

相关实验视频

Last Updated: Jul 27, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.1K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.5K
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

1.5K

科学领域:

  • 神经免疫学 神经免疫学
  • 中枢神经系统 (CNS) 的炎症和脱髓化疾病.

背景情况:

  • 多发性硬化症 (MS) 是一种主要的炎症性脱髓化中枢神经系统疾病.
  • 目前的治疗方法有效地治疗复发,但不能治疗渐进性多发性硬化.
  • 早期疾病进展独立于复发活动是一个重大挑战.

研究的目的:

  • 审查2022年关于MS的出版物.
  • 提供有关MS易感性和疾病进展的见解.
  • 讨论新出现的中枢神经系统炎症/脱线性疾病,如MOGAD.

主要方法:

  • 对2022年发表的科学文献的综述.
  • 综合与多发性硬化症的发病和进展相关的发现.
  • 分析了解MOGAD的最近发展情况.

主要成果:

  • 了解通过免疫调节疗法预防多发性硬化症复发的进展.
  • 识别持续的疾病进展,独立于复发,在MS的早期开始.
  • 作为一个独特的实体,髓类寡腺细胞糖蛋白抗体相关疾病 (MOGAD) 的特征.

结论:

  • 开发进展性多发性硬化症治疗方法仍然是一个关键的挑战.
  • 了解早期疾病机制是阻止疾病进展的关键.
  • 在2022年的研究推进了对MS和MOGAD等相关疾病的理解.